According to Li and colleagues, this gene contributes to the development of CNS-embryonal malignancies by working with the MYC/MYC-associated factor X (MAX) complex and facilitating the growth of cancer cells, as well as by overexpressing in the presence of a Trp53 deficiency [22] (Fig. 4A). This evidence concerns the gene MYC and cancer.